𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability

✍ Scribed by Frank A. Sinicrope; Rafaela L. Rego; Megan M. Garrity-Park; Nathan R. Foster; Daniel J. Sargent; Richard M. Goldberg; Myron Wiesenfeld; Thomas E. Witzig; Stephen N. Thibodeau; Lawrence J. Burgart


Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
195 KB
Volume
120
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Colon cancers with microsatellite instability (MSI) demonstrate a host immune response characterized by tumor infiltrating lymphocytes (TILs) that may exert effects upon tumor cell apoptosis and cell proliferation. Accordingly, we compared rates of apoptosis and cell proliferation in colon cancers with defective DNA mismatch repair and their association with phenotypic features and clinical outcome. Primary Astler‐Coller stage B2 and C colon carcinomas (n = 329) were analyzed for MSI and for hMLH1 and hMSH2 protein expression. Apoptosis (TUNEL assay) and p53 expression were also analyzed by immunohistochemistry, and TILs were quantified by morphology. DNA ploidy and proliferation (PI: S phase + G~2~M) were evaluated using flow cytometry. MSI‐H (n = 58) colon cancers showed increased TILs that were significantly associated with increased apoptosis, higher apoptosis to proliferation (AI/PI) ratios, reduced proliferative indices (PI) and diploid DNA content. Increased TILs (p = 0.036) and reduced PI (p = 0.042), but not AI or AI/PI, were associated with improved disease‐free survival. Tumors with MSI‐H (p = 0.032) or loss of hMLH1 or hMSH2 proteins (p = 0.040), or diploidy (p = 0.0015), had better adjusted overall survival rates. Interestingly, similar rates of cell turnover and overlapping survival rates were found in diploid MSS/MSI‐L tumors and in MSI‐H cases. In conclusion, higher apoptosis/proliferation ratios and reduced cell proliferation are phenotypic features of MSI‐H tumors that are associated with increased TILs, indicating an activated immune response that may contribute to their favorable survival rates. Β© 2006 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Prognostic implications of BAX and TGFBR
✍ Wade S. Samowitz; Karen Curtin; Susan Neuhausen; Donna Schaffer; Martha L. Slatt πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 322 KB

## Abstract Microsatellite instability in sporadic colon cancer is associated with an improved prognosis. Recent studies, however, have suggested that microsatellite unstable cancers with mutations in the proapoptotic gene __BAX__ have a relatively poor prognosis, whereas those with mutations in tr

Microsatellite instability in sporadic-c
✍ Wei-Shone Chen; Jeou Yuan Chen; Jacqueline Ming Liu; Wen Chang Lin; Kuang Liang πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 75 KB πŸ‘ 2 views

Microsatellite instability (MSI) is intrinsic to most colorectal carcinomas (CRC) from patients with hereditary nonpolyposis colorectal cancer (HNPCC), reflecting germline mutations in the mismatch-repair (MMR) genes. Its occurrence and chronological sequence of development in sporadic CRC appears l

Frequent alterations in the Wnt signalin
✍ Yosuke Shimizu; Satoshi Ikeda; Masahiko Fujimori; Shinya Kodama; Masahiro Nakaha πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract It is generally accepted that both dysfunction of the Wnt signaling pathway, including mutations in the adenomatous polyposis coli (__APC__) and β‐catenin genes, and genetic instability play important roles in colorectal carcinogenesis. However, alteration of the components in the Wnt s

The JMJD2A demethylase regulates apoptos
✍ Tae-Dong Kim; Sook Shin; William L. Berry; Sangphil Oh; Ralf Janknecht πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 463 KB

## Abstract JMJD2A is a transcriptional cofactor and enzyme that catalyzes demethylation of histone H3 lysines 9 and 36 and is overexpressed in human tumors, but its role in oncogenesis remains unclear. Here, we show that JMJD2A interacts with the tumor suppressor p53 both in vitro and in HCT116 co